2022
Codiversification of gut microbiota with humans.
Suzuki, T. A., Fitzstevens, L., Schmidt, V.T., Enav‚ H., Huus, K. E., Mbong Ngwese, M., Grießhammer, A., Pfleiderer, A., Adegbite, B., R., Zinsou, J. F., Esen, M., Velavan, T., P., Adegnika, A. A., Huu Song, L., Spector, T. D., Muehlbauer, A. L., Marchi, N., Kang, H., Maier, L., Blekhman, R., Ségurel, L., Ko, G., Youngblut, N. D., Kremser, P., Ley, R. E. (2022).
2021
Unravelling the collateral damage of antibiotics on gut bacteria.
Maier, L.#*, Goemans, C. V.*, Wirbel, J., Kuhn, M., Eberl, C., Pruteanu, M., Müller, P., Garcia-Santamarina, S., Cacace, E., Zhang, B., Gekeler, C., Banerjee, T., Anderson, E. E., Milanese, A., Löber, U., Forslund, S. K., Patil, K. R., Zimmermann, M., Stecher, B., … Typas, A.# (2021).
Nature, 599, pages 120-124
Bioaccumulation of therapeutic drugs by human gut bacteria.
Klünemann, M., Andrejev, S., Blasche, S., Mateus, A., Phapale, P., Devendran, S., Vappiani, J., Simon, B., Scott, T. A., Kafkia, E., Konstantinidis, D., Zirngibl, K., Mastrorilli, E., Banzhaf, M., Mackmull, M.-T., Hövelmann, F., Nesme, L., Brochado, A. R., Maier, L., … Patil, K. R. (2021).
Nature, 597, 533-538
Towards a mechanistic understanding of reciprocal drug-microbiome interactions.
Zimmermann, M.#, Patil, K. R., Typas, A., & Maier, L.# (2021).
Molecular Systems Biology, 17(3), e10116.
2019
Escherichia coli limits Salmonella Typhimurium infections after diet shifts and fat-mediated microbiota perturbation in mice.
Wotzka, S. Y., Kreuzer, M., Maier, L., Arnoldini, M., Nguyen, B. D., Brachmann, A. O., Berthold, D. L., Zünd, M., Hausmann, A., Bakkeren, E., Hoces, D., Gül, E., Beutler, M., Dolowschiak, T., Zimmermann, M., Fuhrer, T., Moor, K., Sauer, U., Typas, A., … Hardt, W.-D. (2019).
Nature Microbiology, 4(12), 2164–2174.
Komplexe Wechselwirkungen zwischen Arzneimitteln und dem Mikrobiom.
Maier, L. (2019).
BIOspektrum, 25(7), 707–710.
2018
Wotzka, S. Y.*, Kreuzer, M.*, Maier, L.*, Zünd, M., Schlumberger, M., Nguyen, B., Fox, M., Pohl, D., Heinrich, H., Rogler, G., Biedermann, L., Scharl, M., Sunagawa, S., Hardt, W.-D., & Misselwitz, B. (2018).
PLOS ONE, 13(10), e0206214.
Extensive impact of non-antibiotic drugs on human gut bacteria.
Maier, L.*, Pruteanu, M.*, Kuhn, M.*, Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., Patil, K. R., Bork, P., & Typas, A. (2018).
Nature, 555(7698), 623–628.
2017
Systematically investigating the impact of medication on the gut microbiome.
Maier, L., & Typas, A. (2017).
Current Opinion in Microbiology, 39, 128–135.
Salt-responsive gut commensal modulates TH17 axis and disease.
Wilck, N., Matus, M. G., Kearney, S. M., Olesen, S. W., Forslund, K., Bartolomaeus, H., Haase, S., Mähler, A., Balogh, A., Markó, L., Vvedenskaya, O., Kleiner, F. H., Tsvetkov, D., Klug, L., Costea, P. I., Sunagawa, S., Maier, L., Rakova, N., Schatz, V., … Müller, D. N. (2017).
Nature, 551(7682), 585–589.
2015
Maier, L., Diard, M., Sellin, M. E., Chouffane, E.-S., Trautwein-Weidner, K., Periaswamy, B., Slack, E., Dolowschiak, T., Stecher, B., Loverdo, C., Regoes, R. R., & Hardt, W.-D. (2014).
PLoS Pathogens, 10(12), e1004557.
Maier, L., Barthel, M., Stecher, B., Maier, R. J., Gunn, J. S., & Hardt, W.-D. (2014).
PLoS ONE, 9(10), e110187.
2013
“Blooming” in the gut: How dysbiosis might contribute to pathogen evolution.
Stecher, B., Maier, L., & Hardt, W.-D. (2013).
Nature Reviews. Microbiology, 11(4), 277–284.
Microbiota-Derived Hydrogen Fuels Salmonella Typhimurium Invasion of the Gut Ecosystem.
Maier, L., Vyas, R., Cordova, C. D., Lindsay, H., Schmidt, T. S. B., Brugiroux, S., Periaswamy, B., Bauer, R., Sturm, A., Schreiber, F., von Mering, C., Robinson, M. D., Stecher, B., & Hardt, W.-D. (2013).
Cell Host & Microbe, 14(6), 641–651.
Stabilization of cooperative virulence by the expression of an avirulent phenotype.
Diard, M., Garcia, V., Maier, L., Remus-Emsermann, M. N. P., Regoes, R. R., Ackermann, M., & Hardt, W.-D. (2013).
Nature, 494(7437), 353–356.
2012
Live attentuated S. Typhimurium vaccine with improved safety in immuno-compromised mice.
Periaswamy, B., Maier, L., Vishwakarma, V., Slack, E., Kremer, M., Andrews-Polymenis, H. L., McClelland, M., Grant, A. J., Suar, M., & Hardt, W.-D. (2012).
PloS One, 7(9), e45433.
Endt, K.*, Maier, L.*, Käppeli, R., Barthel, M., Misselwitz, B., Kremer, M., & Hardt, W.-D. (2012).
Antimicrobial Agents and Chemotherapy, 56(5), 2295–2304.
Stecher, B., Denzler, R., Maier, L., Bernet, F., Sanders, M. J., Pickard, D. J., Barthel, M., Westendorf, A. M., Krogfelt, K. A., Walker, A. W., Ackermann, M., Dobrindt, U., Thomson, N. R., & Hardt, W.-D. (2012).
PNAS, 109(4), 1269–1274.
2010
Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM.
Xia, G., Maier, L., Sanchez-Carballo, P., Li, M., Otto, M., Holst, O., & Peschel, A. (2010).
The Journal of Biological Chemistry, 285(18), 13405–13415.
————————————————————————————————————————
* equal contribution, # corresponding authors